New Vitiligo Treatment in UAE: What It Means for Clinics & Billing Teams
UAE Healthcare Update The UAE has become the first country globally to approve RINVOQ (upadacitinib) for non-segmental vitiligo in adults and adolescents aged 12 and above who require systemic therapy. The Emirates Drug Establishment (EDE) announced the approval on 17 August 2026, adding a new oral treatment pathway for eligible patients. For Dubai clinics, dermatology […]
New Vitiligo Treatment in UAE: What It Means for Clinics & Billing Teams Read More »







